Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin TherapySignificance

  • Karen C. Johnson, Aaron K. Aragaki, Rebecca Jackson, Alex Reiner, Per Morten Sandset, Jan Rosing, Anders E.A. Dahm, Frits Rosendaal, JoAnn E. Manson, Lisa W. Martin, Simin Liu, Lewis H. Kuller, Mary Cushman, Jacques E. Rossouw
  • Arteriosclerosis Thrombosis and Vascular Biology, December 2015, Wolters Kluwer Health
  • DOI: 10.1161/atvbaha.115.306905

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1161/atvbaha.115.306905

The following have contributed to this page: Dr Simin Liu